Funding for this research was provided by:
U.S. Department of Defense (W81XWH-10-1-0972, W81XWH-15-1-0070)
American Cancer Society (RSG14-014-01-CCE)
National Institutes of Health (R01-CA142989, P41-EB0158930)
Chao Family Comprehensive Cancer Center (P30-CA62203)
National Cancer Institute (U01-CA079778, U01-CA080098)
Text and Data Mining valid from 2020-03-13
Received: 13 September 2019
Accepted: 11 February 2020
First Online: 13 March 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board at UC Irvine, Boston University, and Boston Medical Center. All patients provided written informed consent to participate in this study.
: Not applicable.
: BJT, DR, and TO report intellectual property (patents issued and pending) related to DOSI technologies. Some of these patents have been licensed to private companies, but none of the other authors have a financial interest in common with these entities and the DOSI instrumentation used in this study was constructed in a university laboratory using federal grant support (NIH). The other authors declare that they have no competing interests.